Eli Lilly  Announces It Will Present 19 Scientific Abstracts For Emgality (Galcanezumab-Gnlm) And Lasmiditan At The 71St Annual Meeting Of The American Academy Of Neurology Taking Place In Philadelphia From May 4-10